Particle Size Analysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The global particle size analysis market was valued at USD 357.6 million in 2020, and it is expected to reach USD 481.78 million by 2026, registering a CAGR of 5.1% during the period from 2021 to 2026. COVID -19 outbreak, scientists are involved in developing antivirals and vaccines to treat patients. China has given its nod for researchers to begin human safety tests for an experimental vaccine to treat COVID -19. A vaccine to protect against COVID -19 is urgently needed. In the recent past, researchers aimed at assessing the safety, tolerability, and immunogenicity of a recombinant adenovirus type - 5 (Ad 5 ) vectored COVID -19 vaccine, expressing the spike in the glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS -CoV - 2 ) strain. Further, ongoing research to find a promising vaccine is mostly on the trial period, and the usage of particle size analysis is significantly increasing.
Key HighlightsThe particle size analysis market is moderately competitive and consists of several major players. In terms of market share, a few of the significant players are dominating the market. However, with the growing demand across various end-user industries, most of the companies are expanding their business footprints among emerging economies. Also, the level of market penetration of the particle size analyzers is very high, and innovations and patents are filed every year. Market incumbents that have substantial R&D capabilities or startups with top product distinction often prosper in the market. Key players are Malvern Panalytical Ltd, Horiba Ltd, Agilent Technologies Inc., etc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook